Tune CEO Matt Kane. (Tune Photo)A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40 million in new funding and a
Tune Therapeutics receives $40M funding. It aims to tune the activity of genes within cells.
brostrommask1973
December 10, 2021
Software
business technology
http://chieftechnologyofficer.blog/business-technology/tune-therapeutics-receives-40m-funding-it-aims-to-tune-the-activity-of-genes-within-cells